SVF

Clinical trials

SVF clinical trials tracker

A registered trial means the question is still being studied — not that the treatment is proven.

  • NCT05123456RecruitingPhase 2

    Intra-articular SVF Injection in Moderate Knee Osteoarthritis

    Single autologous adipose-derived SVF injection versus saline.

    Sponsor
    Mahidol University
    Country
    Thailand
    Enrollment
    120
    Timeline
    2024-06-01 → 2027-05-31

    Inclusion

    • • Age 45–75 years
    • • Knee OA Kellgren-Lawrence grade 2–3

    Exclusion

    • • Prior knee replacement
    • • Active joint infection
    Trial detailsView registry record
  • NCT04987654ActivePhase 2

    SVF-Enriched Facial Fat Grafting: Graft Retention Study

    SVF-enriched fat grafting versus standard fat grafting.

    Sponsor
    University Hospital Seoul
    Country
    South Korea
    Enrollment
    60
    Timeline
    2023-02-15 → 2026-12-31

    Inclusion

    • • Age 30–65 years

    Exclusion

    • • Heavy smoking
    • • Pregnancy
    Trial detailsView registry record
  • NCT05334422RecruitingPhase 1/2

    SVF for Chronic Diabetic Foot Ulcers

    Peri-wound SVF injection plus standard wound care.

    Sponsor
    Chulalongkorn University
    Country
    Thailand
    Enrollment
    48
    Timeline
    2025-01-20 → 2027-01-31

    Inclusion

    • • Ulcer present more than 6 weeks

    Exclusion

    • • Severe ischemia requiring vascular surgery
    Trial detailsView registry record
  • NCT04771122ActivePhase 1

    SVF in Stage 3–4 Chronic Kidney Disease

    Single intravenous SVF administration.

    Sponsor
    Kyoto Regenerative Institute
    Country
    Japan
    Enrollment
    24
    Timeline
    2024-09-02 → 2026-10-31

    Inclusion

    • • eGFR 20–45 mL/min/1.73m²

    Exclusion

    • • Currently on dialysis
    Trial detailsView registry record
  • NCT05559911RecruitingPhase 2

    SVF for Male Androgenetic Alopecia

    Single scalp SVF injection.

    Sponsor
    Barcelona Dermatology Center
    Country
    Spain
    Enrollment
    80
    Timeline
    2025-04-14 → 2027-06-30

    Inclusion

    • • Norwood scale 3–5

    Exclusion

    • • Finasteride use within 3 months
    Trial detailsView registry record
  • NCT04665533CompletedPhase 1/2

    SVF for Lumbar Degenerative Disc Disease

    Intradiscal SVF injection.

    Sponsor
    Cleveland Spine Research Network
    Country
    United States
    Enrollment
    36
    Timeline
    2021-03-08 → 2025-09-30

    Inclusion

    • • Chronic low back pain over 6 months

    Exclusion

    • • Nerve compression requiring surgery
    Trial detailsView registry record